Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis

[1] Smith A(2015)Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK/'s Haematological malignancy research network Br J Cancer 112 1575-1584

[2] Crouch S(2009)Hodgkin lymphoma: an update on its biology with new insights into classification Clin Lymphoma Myeloma 9 206-216

[3] Lax S(2014)Hodgkin's lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up† Ann Oncol 25 iii70-iii75

[4] Li J(2005)Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's study group J Clin Oncol 23 5052-5060

[5] Painter D(2004)VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study Ann Oncol 15 123-128

[6] Howell D(2002)Northern region lymphoma G: Hodgkin's disease in the elderly: a population-based study Br J Haematol 119 432-440

[7] Patmore R(2010)Hematology: are macrophages the bad guys in Hodgkin lymphoma? Nat Rev Clin Oncol 7 301-302

[8] Jack A(2016)Prognostic factors in Hodgkin lymphoma Semin Hematol 53 155-164

[9] Roman E(2009)Late effects of Hodgkin's disease and its treatment Cancer J 15 164-168

[10] Mani H(2002)Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial Lancet 359 2065-2071

[1] Smith A(2015)Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK/'s Haematological malignancy research network Br J Cancer 112 1575-1584

[2] Crouch S(2009)Hodgkin lymphoma: an update on its biology with new insights into classification Clin Lymphoma Myeloma 9 206-216

[3] Lax S(2014)Hodgkin's lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up† Ann Oncol 25 iii70-iii75

[4] Li J(2005)Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's study group J Clin Oncol 23 5052-5060

[5] Painter D(2004)VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study Ann Oncol 15 123-128

[6] Howell D(2002)Northern region lymphoma G: Hodgkin's disease in the elderly: a population-based study Br J Haematol 119 432-440

[7] Patmore R(2010)Hematology: are macrophages the bad guys in Hodgkin lymphoma? Nat Rev Clin Oncol 7 301-302

[8] Jack A(2016)Prognostic factors in Hodgkin lymphoma Semin Hematol 53 155-164

[9] Roman E(2009)Late effects of Hodgkin's disease and its treatment Cancer J 15 164-168

[10] Mani H(2002)Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial Lancet 359 2065-2071